Total Payments
$11,270
2024 Payments
$5,633
Companies
56
Transactions
489
Medicare Patients
5,397
Medicare Billing
$995,277
Payment Breakdown by Category
Food & Beverage$8,292 (73.6%)
Consulting$2,205 (19.6%)
Travel$667.10 (5.9%)
Education$106.22 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,292 | 470 | 73.6% |
| Consulting Fee | $2,205 | 1 | 19.6% |
| Travel and Lodging | $667.10 | 2 | 5.9% |
| Education | $106.22 | 7 | 0.9% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$11,270
480 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $3,244 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $879.30 | 67 | $0 (2024) |
| Daiichi Sankyo Inc. | $779.93 | 42 | $0 (2024) |
| PFIZER INC. | $597.87 | 55 | $0 (2024) |
| Merck Sharp & Dohme LLC | $476.43 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $359.66 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $339.92 | 31 | $0 (2024) |
| Amgen Inc. | $316.28 | 19 | $0 (2023) |
| GENZYME CORPORATION | $298.84 | 16 | $0 (2024) |
| Celgene Corporation | $297.20 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,633 | 162 | Genentech USA, Inc. ($3,125) |
| 2023 | $2,640 | 161 | Novartis Pharmaceuticals Corporation ($348.43) |
| 2022 | $1,692 | 101 | Novartis Pharmaceuticals Corporation ($212.87) |
| 2021 | $139.76 | 9 | GENZYME CORPORATION ($40.29) |
| 2020 | $278.93 | 12 | Rigel Pharmaceuticals, Inc. ($111.38) |
| 2019 | $478.51 | 28 | PFIZER INC. ($133.95) |
| 2018 | $355.63 | 13 | Taiho Oncology, Inc. ($115.37) |
| 2017 | $51.67 | 3 | Novartis Pharmaceuticals Corporation ($36.78) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Oncology | ||||||
| 12/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $44.57 | General |
| 12/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.89 | General |
| 12/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Oncology | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Genentech USA, Inc. | Itovebi (Biological), Kadcyla, Perjeta | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: BioOncology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,176 | 6,141 | $509,116 | $140,435 |
| 2022 | 36 | 1,381 | 22,699 | $652,327 | $250,038 |
| 2021 | 32 | 1,454 | 12,032 | $687,908 | $317,004 |
| 2020 | 31 | 1,386 | 10,525 | $644,992 | $287,801 |
Total Patients
5,397
Total Services
51,397
Medicare Billing
$995,277
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 508 | $93,472 | $45,868 | 49.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 25 | 157 | $54,950 | $14,813 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 103 | $25,544 | $12,940 | 50.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 88 | $125,136 | $11,798 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 181 | $22,625 | $10,825 | 47.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 167 | 676 | $39,208 | $6,945 | 17.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 180 | 779 | $27,265 | $5,855 | 21.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 113 | $15,820 | $5,159 | 32.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $9,912 | $4,551 | 45.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 19 | 188 | $14,288 | $3,973 | 27.8% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 19 | 218 | $9,374 | $3,690 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,415 | $2,307 | 42.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 181 | $7,964 | $1,867 | 23.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 20 | 73 | $6,424 | $1,315 | 20.5% |
| 84165 | Protein measurement, serum | Office | 2023 | 22 | 111 | $6,660 | $1,169 | 17.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 42 | 77 | $4,312 | $1,029 | 23.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 47 | $4,230 | $889.96 | 21.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 17 | 54 | $4,104 | $888.84 | 21.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 31 | $2,728 | $755.70 | 27.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 12 | 24 | $2,112 | $606.96 | 28.7% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 11 | 66 | $2,640 | $601.26 | 22.8% |
| 83550 | Iron binding capacity | Office | 2023 | 39 | 69 | $2,277 | $591.33 | 26.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 34 | $2,108 | $490.25 | 23.3% |
| 83540 | Iron level | Office | 2023 | 39 | 69 | $1,725 | $437.46 | 25.4% |
| 82746 | Folic acid level, serum | Office | 2023 | 24 | 27 | $1,620 | $389.07 | 24.0% |
About Dr. Gregory Chipman, M.D
Dr. Gregory Chipman, M.D is a Hematology & Oncology healthcare provider based in American Fork, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457493967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Chipman, M.D has received a total of $11,270 in payments from pharmaceutical and medical device companies, with $5,633 received in 2024. These payments were reported across 489 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($8,292).
As a Medicare-enrolled provider, Chipman has provided services to 5,397 Medicare beneficiaries, totaling 51,397 services with total Medicare billing of $995,277. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location American Fork, UT
- Active Since 02/12/2007
- Last Updated 10/10/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1457493967
Products in Payments
- Enhertu (Drug) $564.58
- KEYTRUDA (Biological) $432.04
- IMBRUVICA (Drug) $248.78
- SCEMBLIX (Drug) $244.75
- KISQALI (Drug) $237.54
- Lenvima (Drug) $226.47
- IBRANCE (Drug) $218.41
- OPDIVO (Biological) $190.01
- Tivdak (Drug) $172.15
- INLYTA (Drug) $160.26
- JEMPERLI (Biological) $144.57
- Nplate (Biological) $137.84
- TASIGNA (Drug) $137.59
- VERZENIO (Drug) $132.73
- ENHERTU (Drug) $129.20
- MONJUVI (Drug) $126.28
- JAKAFI (Drug) $120.38
- Pomalyst (Drug) $116.86
- Lonsurf (Drug) $115.37
- IMFINZI (Biological) $114.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.